Meta-analysis of pancreatic re-resection for locally recurrent pancreatic cancer following index pancreatectomy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Repeat surgery for recurrent pancreatic cancer offers acceptable survival. Selective re-resection is recommended for younger patients with favorable tumor characteristics, improving outcomes for pancreatic cancer recurrence.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- The efficacy of surgical intervention for recurrent pancreatic cancer remains uncertain.
- Index pancreatectomy is a primary treatment, but local recurrence necessitates further management strategies.
Purpose Of The Study
- To evaluate the survival outcomes associated with pancreatic re-resection in patients experiencing locally recurrent pancreatic cancer after an initial pancreatectomy.
- To provide evidence-based recommendations for managing pancreatic cancer recurrence.
Main Methods
- A comprehensive literature search was conducted across major biomedical databases (CENTRAL, EMBASE, MEDLINE, CINAHL, Web of Science).
- A proportion meta-analysis using random-effects modeling was employed to synthesize survival data from 15 retrospective studies involving 250 patients.
Main Results
- Pancreatic re-resection demonstrated 1-year survival of 70.6%, 2-year survival of 38.8%, 3-year survival of 20.2%, and 5-year survival of 9.2%.
- No significant heterogeneity was observed between the included studies for any survival outcome.
Conclusions
- Repeat pancreatectomy for locally recurrent pancreatic cancer in the remnant pancreas is linked to acceptable patient survival.
- Selective re-resection is advised for younger patients with favorable tumor size and location, warranting further robust studies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
